New recommendations in the treatment of Gram-positive bacteraemia in dialysis patients

Nephrology Dialysis Transplantation

Volumn 23, Issue 7, 2008, Pages 2431-2432

  Labriola, Laura ^a   Jadoul, Michel ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEFAZOLIN; CEPHALOSPORIN; THROMBOCYTE ANTIBODY; VANCOMYCIN;

ANTIBIOTIC THERAPY; ANTIMICROBIAL LOCK SOLUTION; BACTEREMIA; CATHETER CARE; CATHETER INFECTION; CLINICAL TRIAL; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; GRAM POSITIVE BACTERIUM; HEMODIALYSIS PATIENT; HOSPITALIZATION; HUMAN; HYGIENE; INCIDENCE; INTENSIVE CARE UNIT; LETTER; LIVER TOXICITY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEUTROPENIA; PRIORITY JOURNAL; SKIN MANIFESTATION; TECHNIQUE; THROMBOCYTOPENIA; VIRUS STRAIN;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTEREMIA; CEPHALOSPORINS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; RENAL DIALYSIS; THROMBOCYTOPENIA; VANCOMYCIN;

EID: 46849086949     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn193     Document Type: Letter

References (5)

1. Ponticelli C. New recommendations in the treatment of Gram-positive bacteraemia in dialysis patients. Nephrol Dial Transplant 2008; 23: 27-32
2. Fogel MA, Nussbaum PP, Feintzeig ID et al. Cefazolin in chronic haemodialysis patients: a safe, effective alternative to vancomycin. Am J Kidney Dis 1998; 32: 401-409
3. Centers for Disease Control and Prevention (CDC). Invasive methicillin-resistant Staphylococcus aureus infections among dialysis patients - United States 2005. MMWR Morb Mortal Wkly Rep 2007; 56: 197-199
4. Labriola L, Crott R, Jadoul M. Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials. Nephrol Dial Trsansplant 2007; 23: 1666-1672
5. Von Drygalski A, Curtis BR, Bougie DW et al. Vancomycin-induced immune thrombocytopenia. N Engl J Med 2007; 356: 904-910